Screener
Lazard LAZ Redeemable NCI
Redeemable NCI at other companies
Other financials
Where this comes from
Reported directly by Lazard in its filing.
Tagged under the XBRL concept us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount.
The source filing: Lazard’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:33 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001311370-26-000022
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Other liabilities | 456,020 | 651,395 |
| Total Liabilities | 3,348,843 | 3,951,604 |
| Commitments and contingencies | ||
| Redeemable noncontrolling interests | 111,286 | $78,379 |
| STOCKHOLDERS’ EQUITY | ||
| Preferred stock, par value $0.01 per share; 15,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | – | – |
| Common stock: | ||
| Par value $0.01 per share (500,000,000 shares authorized; 110,548,172 and 111,728,757 shares issued at June 30, 2026 and December 31, 2025, respectively, including shares held in treasury) | 1,105 | 1,117 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Lazard's redeemable NCI?
- Lazard (LAZ) reported redeemable NCI of $111.29M in Q2 2026.
- How has Lazard's redeemable NCI changed year-over-year?
- Lazard's redeemable NCI increased by 33.2% year-over-year, from $83.58M to $111.29M.
- What is the long-term trend for Lazard's redeemable NCI?
- Over 4 years (2021 to 2025), Lazard's redeemable NCI has grown at a -39.2% compound annual growth rate (CAGR), from $575M to $78.38M.
- What does redeemable NCI mean?
- Minority interests in subsidiaries that include a put option allowing the minority holder to require the parent to repurchase their stake.
Ask your AI about Lazard's redeemable nci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude